253 related articles for article (PubMed ID: 18055545)
21. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.
Lue LF; Yan SD; Stern DM; Walker DG
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):249-66. PubMed ID: 15975028
[TBL] [Abstract][Full Text] [Related]
22. Cerebrovascular pathology during the progression of experimental Alzheimer's disease.
Giannoni P; Arango-Lievano M; Neves ID; Rousset MC; Baranger K; Rivera S; Jeanneteau F; Claeysen S; Marchi N
Neurobiol Dis; 2016 Apr; 88():107-17. PubMed ID: 26774030
[TBL] [Abstract][Full Text] [Related]
23. Role of Blood-Brain Barrier in Alzheimer's Disease.
Cai Z; Qiao PF; Wan CQ; Cai M; Zhou NK; Li Q
J Alzheimers Dis; 2018; 63(4):1223-1234. PubMed ID: 29782323
[TBL] [Abstract][Full Text] [Related]
24. Traffic jam at the blood-brain barrier promotes greater accumulation of Alzheimer's disease amyloid-β proteins in the cerebral vasculature.
Agyare EK; Leonard SR; Curran GL; Yu CC; Lowe VJ; Paravastu AK; Poduslo JF; Kandimalla KK
Mol Pharm; 2013 May; 10(5):1557-65. PubMed ID: 23249146
[TBL] [Abstract][Full Text] [Related]
25. Evidence for altered LRP/RAGE expression in Alzheimer lesion pathogenesis.
Jeynes B; Provias J
Curr Alzheimer Res; 2008 Oct; 5(5):432-7. PubMed ID: 18855584
[TBL] [Abstract][Full Text] [Related]
26. Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway.
Kang DE; Pietrzik CU; Baum L; Chevallier N; Merriam DE; Kounnas MZ; Wagner SL; Troncoso JC; Kawas CH; Katzman R; Koo EH
J Clin Invest; 2000 Nov; 106(9):1159-66. PubMed ID: 11067868
[TBL] [Abstract][Full Text] [Related]
27. Amyloid-beta-induced degeneration of human brain pericytes is dependent on the apolipoprotein E genotype.
Verbeek MM; Van Nostrand WE; Otte-Höller I; Wesseling P; De Waal RM
Ann N Y Acad Sci; 2000 Apr; 903():187-99. PubMed ID: 10818507
[TBL] [Abstract][Full Text] [Related]
28. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.
Donahue JE; Flaherty SL; Johanson CE; Duncan JA; Silverberg GD; Miller MC; Tavares R; Yang W; Wu Q; Sabo E; Hovanesian V; Stopa EG
Acta Neuropathol; 2006 Oct; 112(4):405-15. PubMed ID: 16865397
[TBL] [Abstract][Full Text] [Related]
29. Rapid degeneration of cultured human brain pericytes by amyloid beta protein.
Verbeek MM; de Waal RM; Schipper JJ; Van Nostrand WE
J Neurochem; 1997 Mar; 68(3):1135-41. PubMed ID: 9048759
[TBL] [Abstract][Full Text] [Related]
30. Extracellular matrix modulator lysyl oxidase colocalizes with amyloid-beta pathology in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis--Dutch type.
Wilhelmus MM; Bol JG; van Duinen SG; Drukarch B
Exp Gerontol; 2013 Feb; 48(2):109-14. PubMed ID: 23267843
[TBL] [Abstract][Full Text] [Related]
31. Three lipoprotein receptors and cholesterol in inclusion-body myositis muscle.
Jaworska-Wilczynska M; Wilczynski GM; Engel WK; Strickland DK; Weisgraber KH; Askanas V
Neurology; 2002 Feb; 58(3):438-45. PubMed ID: 11839845
[TBL] [Abstract][Full Text] [Related]
32. Lipopolysaccharide impairs amyloid β efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier.
Erickson MA; Hartvigson PE; Morofuji Y; Owen JB; Butterfield DA; Banks WA
J Neuroinflammation; 2012 Jun; 9():150. PubMed ID: 22747709
[TBL] [Abstract][Full Text] [Related]
33. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles.
Natté R; Maat-Schieman ML; Haan J; Bornebroek M; Roos RA; van Duinen SG
Ann Neurol; 2001 Dec; 50(6):765-72. PubMed ID: 11761474
[TBL] [Abstract][Full Text] [Related]
34. Nanoformulated alpha-mangostin ameliorates Alzheimer's disease neuropathology by elevating LDLR expression and accelerating amyloid-beta clearance.
Yao L; Gu X; Song Q; Wang X; Huang M; Hu M; Hou L; Kang T; Chen J; Chen H; Gao X
J Control Release; 2016 Mar; 226():1-14. PubMed ID: 26836197
[TBL] [Abstract][Full Text] [Related]
35. Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes.
Utter S; Tamboli IY; Walter J; Upadhaya AR; Birkenmeier G; Pietrzik CU; Ghebremedhin E; Thal DR
J Neuropathol Exp Neurol; 2008 Sep; 67(9):842-56. PubMed ID: 18716559
[TBL] [Abstract][Full Text] [Related]
36. Small cerebral vessel disease in familial amyloid and non-amyloid angiopathies: FAD-PS-1 (P117L) mutation and CADASIL. Immunohistochemical and ultrastructural studies.
Szpak GM; Lewandowska E; Wierzba-Bobrowicz T; Bertrand E; Pasennik E; Mendel T; Stepień T; Leszczyńska A; Rafałowska J
Folia Neuropathol; 2007; 45(4):192-204. PubMed ID: 18176893
[TBL] [Abstract][Full Text] [Related]
37. Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition.
Jaeger LB; Dohgu S; Hwang MC; Farr SA; Murphy MP; Fleegal-DeMotta MA; Lynch JL; Robinson SM; Niehoff ML; Johnson SN; Kumar VB; Banks WA
J Alzheimers Dis; 2009; 17(3):553-70. PubMed ID: 19433890
[TBL] [Abstract][Full Text] [Related]
38. Influence of LRP-1 and apolipoprotein E on amyloid-β uptake and toxicity to cerebrovascular smooth muscle cells.
Ruzali WA; Kehoe PG; Love S
J Alzheimers Dis; 2013; 33(1):95-110. PubMed ID: 22914594
[TBL] [Abstract][Full Text] [Related]
39. A 3'-UTR polymorphism in the oxidized LDL receptor 1 gene increases Abeta40 load as cerebral amyloid angiopathy in Alzheimer's disease.
Shi J; Tian J; Pritchard A; Lendon C; Lambert JC; Iwatsubo T; Mann DM
Acta Neuropathol; 2006 Jan; 111(1):15-20. PubMed ID: 16328515
[TBL] [Abstract][Full Text] [Related]
40. High-definition characterization of cerebral β-amyloid angiopathy in Alzheimer's disease.
Soontornniyomkij V; Choi C; Pomakian J; Vinters HV
Hum Pathol; 2010 Nov; 41(11):1601-8. PubMed ID: 20688356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
